Your browser doesn't support javascript.
loading
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.
Kostopoulos, Ioannis V; Fotiou, Despina; Gavriatopoulou, Maria; Rousakis, Pantelis; Ntanasis-Stathopoulos, Ioannis; Panteli, Chrysanthi; Malandrakis, Panagiotis; Migkou, Magdalini; Angelis, Nikolaos; Kanellias, Nikolaos; Eleutherakis-Papaiakovou, Evangelos; Theodorakakou, Foteini; Krevvata, Maria; Terpos, Evangelos; Dimopoulos, Meletios-Athanasios; Tsitsilonis, Ourania; Kastritis, Efstathios.
Afiliación
  • Kostopoulos IV; Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Fotiou D; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Rousakis P; Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Panteli C; Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Malandrakis P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Migkou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Angelis N; Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Kanellias N; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Theodorakakou F; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Krevvata M; Janssen Research & Development, Spring House, PA, USA.
  • Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsitsilonis O; Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. ekastritis@med.uoa.gr.
Blood Cancer J ; 14(1): 26, 2024 02 06.
Article en En | MEDLINE | ID: mdl-38321005
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article País de afiliación: Grecia